australians-will-soon-be-able-to-get-a-wegovy-pill

Australians Will Soon Be Able to Get a Wegovy Pill Instead of a Weekly Jab

A single white tablet in an open palm beside a glass of water on a kitchen bench

For Australians on these weight-loss drugs, it’s been a needle. Once a week. Now the TGA has signed off on a Wegovy pill you take every day.

The Therapeutic Goods Administration gave it the tick on Tuesday. It’s the first GLP-1 the TGA has approved in oral form, the ABC reported.

Novo Nordisk makes it. Danish company. Same mob behind the Wegovy injection.

The news landed late Tuesday night. The ABC had it just before 11.30pm.

Who can actually get it?

You’ll need a script. No doctor, no pill.

Who’s it for? People with obesity. Also people who need their cardiovascular risk brought down.

It’s already out in the United States. Europe too. Demand there went through the roof.

Only needles until now

Ozempic. Wegovy. Mounjaro. Here, they’ve all been injections.

GLP-1s copy a gut hormone. Basically, you feel full sooner.

The drug makers have copped some heat too. Their ads got called “unethical” last year. That one was in the ABC as well.

Why is the pill 25 mg?

The jab’s top dose is 2.4 mg. So why’s the biggest tablet 25 mg?

Swallow it and your body doesn’t soak up as much. So you need more. One 25 mg tablet does the same job as a 2.4 mg jab, the ABC said.

There are four strengths. 1.5 mg, 4 mg, 9 mg and 25 mg. That came from a TGA spokesperson.

Most people start on the lowest one. Then they work up toward 25 mg. You take it once a day on an empty stomach, Prevention says.

What’s it going to cost?

Nobody’s said yet. There’s no Australian price guide.

In the US the pill is generally cheaper than the injection. Even though each tablet has more semaglutide in it.

What about the PBS? Not much help, for most people. Under the current rules it only subsidises weight-loss drugs for people with type 2 diabetes.

So anyone else could be paying full whack. At least for now.

Approval’s one thing. Price is another. That bit’s not up to the TGA.

How big is it over there?

Big. Three million prescriptions in the US. That was just the first five months this year.

Australia? Novo Nordisk had flagged it as a priority market. The ABC asked the company for comment.

Not on shelves just yet

There’s still one more step. The TGA has to check the packaging. Then the production processes. Quality stuff, basically.

Only after that can it be released. Pharmacies have to wait till then. Same regulator that looks after sunscreen, by the way. Remember the sunscreen reforms?

How long will that take? The ABC reckons it’s expected before Christmas.

Mounjaro’s maker wants in too

Eli Lilly makes Mounjaro. It’s got its own weight-loss pill as well.

Mounjaro’s the jab. This one you swallow. It’s a different drug.

It’s called orforglipron. It’s sitting with the TGA now. No decision yet.

Until this week? Needle or nothing. Once a week, every week.